Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandner

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Cardiovascular Research|June 14, 2002
Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertensionFriedrich C Blumberg, Cornelia Lorenz, Konrad Wolf, et al.
The Journal of Sexual Medicine|August 4, 2011
Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesiclesStefan Ückert, Eginhard S Waldkirch, Joachim E Sonnenberg, et al.
Frontiers in Pharmacology|August 6, 2019
Protein Kinase G Is Involved in Acute but Not in Long-Term Regulation of Renin SecretionAndrea Schramm, Frank Schweda, Maria Luisa S Sequeira-Lopez, et al.
Handbook of Experimental Pharmacology|July 6, 2019
Correction to: Soluble Guanylate Cyclase Stimulators and ActivatorsPeter Sandner, Daniel P Zimmer, G Todd Milne, et al.
European Urology|August 16, 2011
Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failureAlexandra Oudot, Delphine Behr-Roussel, Sarah Poirier, et al.
Handbook of Experimental Pharmacology|January 29, 2019
Soluble Guanylate Cyclase Stimulators and ActivatorsPeter Sandner, Daniel P Zimmer, G Todd Milne, et al.
Pharmacological Research|October 26, 2023
Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?Ellis Nelissen, Melissa Schepers, Laura Ponsaerts, et al.
Experimental Cell Research|September 28, 2015
Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cellsChristoph Zenzmaier, Johann Kern, Martin Heitz, et al.
FEBS Open Bio|April 12, 2017
Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosisElisabeth Schinner, Veronika Wetzl, Andrea Schramm, et al.
European Journal of Pharmacology|June 1, 2022
Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitisOzgu Aydogdu, Fernando Perez, Patrik Aronsson, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Cardiovascular Research|June 14, 2002
Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertensionFriedrich C Blumberg, Cornelia Lorenz, Konrad Wolf, et al.
The Journal of Sexual Medicine|August 4, 2011
Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesiclesStefan Ückert, Eginhard S Waldkirch, Joachim E Sonnenberg, et al.
Frontiers in Pharmacology|August 6, 2019
Protein Kinase G Is Involved in Acute but Not in Long-Term Regulation of Renin SecretionAndrea Schramm, Frank Schweda, Maria Luisa S Sequeira-Lopez, et al.
Handbook of Experimental Pharmacology|July 6, 2019
Correction to: Soluble Guanylate Cyclase Stimulators and ActivatorsPeter Sandner, Daniel P Zimmer, G Todd Milne, et al.
European Urology|August 16, 2011
Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failureAlexandra Oudot, Delphine Behr-Roussel, Sarah Poirier, et al.
Handbook of Experimental Pharmacology|January 29, 2019
Soluble Guanylate Cyclase Stimulators and ActivatorsPeter Sandner, Daniel P Zimmer, G Todd Milne, et al.
Pharmacological Research|October 26, 2023
Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?Ellis Nelissen, Melissa Schepers, Laura Ponsaerts, et al.
Experimental Cell Research|September 28, 2015
Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cellsChristoph Zenzmaier, Johann Kern, Martin Heitz, et al.
FEBS Open Bio|April 12, 2017
Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosisElisabeth Schinner, Veronika Wetzl, Andrea Schramm, et al.
European Journal of Pharmacology|June 1, 2022
Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitisOzgu Aydogdu, Fernando Perez, Patrik Aronsson, et al.
Pageof 11